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Abstract: The kinetics of dithiothreitol (DTT)-induced aggregation of human recombinant 
insulin and the effect of -crystallin, a representative of the family of small heat shock 
proteins,  on  the  aggregation  process  have  been  studied  using  dynamic  light  scattering 
technique. Analysis of the distribution of the particles by size measured in the course of 
aggregation  showed  that  the  initial  stage  of  the  aggregation  process  was  the  stage  of 
formation of the start aggregates with a hydrodynamic radius (Rh) of about 90 nm. When 
studying the effect of -crystallin on the rate of DTT-induced aggregation of insulin, it  
was  demonstrated  that  low  concentrations  of  -crystallin  dramatically  accelerated  the 
aggregation  process,  whereas  high  concentrations  of  -crystallin  suppressed  insulin 
aggregation. In the present study, at the molar stoichiometric ratio (insulin:-crystallin) 
less than 1:0.5, a pronounced accelerating effect of -crystallin was observed; whereas a 
ratio  exceeding  the  value  of  1:0.6  caused  suppression  of  insulin  aggregation.  The 
mechanisms underlying the dual effect of -crystallin have been proposed. It is assumed 
that heterogeneous nucleation occurring on the surface of the -crystallin particle plays the 
key role in the paradoxical acceleration of insulin aggregation by -crystallin that may 
provide an alternative biologically significant pathway of the aggregation process. 
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1. Introduction 
-Crystallin, a member of the small heat shock protein (Hsp) family, functions as a molecular 
chaperone by interacting with unfolded or misfolded proteins to prevent their aggregation [1]. It has a 
broad  molecular  mass  distribution  of  300  to  1000  kDa  and  forms  large  oligomer  assemblies  that 
display great heterogeneity [2].  
In a previous paper [3], we investigated the effect of -crystallin on the kinetics of dithiothreitol 
(DTT)-induced  aggregation  of  -lactalbumin  using  dynamic  light  scattering  (DLS).  At  all 
concentrations of -crystallin studied, the chaperone induced an increase in the duration of the lag 
period  on  the  dependences  of  the  light  scattering  intensity  on  time.  However,  at  relatively  low 
concentrations  of  -crystallin,  an  increase  in  the  initial  rate  of  aggregation  registered  after  the 
completion of the lag period was observed.  
To reveal the molecular mechanisms of the accelerating effect of low concentrations of -crystallin, 
we decided to study the kinetics of DTT-induced aggregation of a number of other protein substrates. 
In  the  present  work  we  investigated  the  effect  of  -crystallin  on  the  kinetics  of  DTT-induced 
aggregation of human recombinant insulin in a wide range of the -crystallin concentrations. This 
choice was determined by the following considerations: On one hand, the development of modern 
concepts of protein folding and aggregation has resulted in the discovery of numerous nonpathogenic 
proteins  and  peptides,  having  the  ability  to  form  amyloid-like  structures,  which  can  induce 
conformational diseases [4].  Insulin  is  especially  interesting in  this  aspect  because aggregation of 
insulin induced by disorder in its native structure can cause numerous pathological states. Studies of 
the protective role of chaperone-like proteins that prevent insulin aggregation may be important for 
neuroendocrinology, as many pathogenetic problems of a neurodegenerative nature and several other 
diseases are associated with dysfunctions of insulin [5]. 
On the other hand, insulin is widely used as a model substrate in folding studies since it forms 
various oligomeric forms and supramolecular structures as a result of self-assembly or aggregation  
[6–8]. The protein hormone insulin is synthesized in the β cells of the pancreas where it is stored as a  
Zn
2+-containing  hexamer.  Its  large  size,  however,  prevents  its  efficient  absorption  into  the  blood 
stream.  Hexamers  are  therefore  broken  down  to  dimers  and  then  monomers  that  are  transported 
efficiently into the blood stream [6]. The circulating biologically active form of insulin is a Zn
2+-free 
monomer  consisting  of  two  chains  linked  by  two  disulfide  bridges.  Insulin  can  be  induced  to 
aggregation by the reduction of S–S bridges between its A and B chains resulting in their dissociation 
and  formation  of  amorphous  aggregates,  but  under  non-physiological  conditions,  such  as  high 
temperatures  (60–70 C),  low  pH  (1.5–2.0)  and  relatively  high  protein  concentrations,  insulin 
generates amyloid-like fibrils [9–11].  
Therefore, it is becoming increasingly important to study the structural transformations of insulin, 
especially under conditions that promote more extensive aggregation processes, not only from the 
point of view of the long-term storage or pharmaceutical use of insulin, but also for the more general 
insight it may provide into the processes of protein aggregation. In spite of extensive studies [12–21], the Int. J. Mol. Sci. 2010, 11                       
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mechanisms  involved  in  aggregation  of  insulin  under  stress  conditions,  and  in  the  interaction  of 
-crystallin with the denatured substrate thereby influencing its aggregation, are far from being clear. 
In this paper, a detailed study of the kinetics of DTT-induced aggregation of insulin in the absence 
and presence of -crystallin has been performed. The measurements of the light scattering intensity 
and the size distribution of protein particles formed in the course of aggregation allowed us to develop 
the  mechanisms  underlying  seemingly  paradoxical  accelerating  effect  of  low  concentrations 
of -crystallin.  
2. Results 
2.1. Kinetics of Dithiothreitol-Induced Aggregation of Insulin 
DTT-induced aggregation of insulin was studied by DLS at 25 C in 50 mM sodium phosphate 
buffer,  pH  7.0,  containing  0.15  M  NaCl  at  various  concentrations  of  the  protein.  Figure  1A 
demonstrates  the  increase  in  the  light  scattering  intensity  (I)  in  time  accompanying  DTT-induced 
aggregation  of  insulin.  The  increase  in  the  concentration  of  insulin  in  the  interval  from  0.2  to 
0.4 mg/mL resulted in the increase to the aggregation rate (curves 1–6).  
Figure 1. Kinetics of DTT-induced aggregation of insulin. The dependences of the light 
scattering intensity (I) on time obtained at 25  C in 50 mM sodium phosphate buffer, 
pH 7.0, containing 0.15 M NaCl and 20 mM DTT (A). The concentrations of insulin were 
as  follows:  0.20  (1),  0.24  (2),  0.28  (3),  0.32  (4),  0.36  (5)  and  0.40  (6)  mg/mL.  The 
dependence  of  parameter  Kagg  on  the  concentration  of  insulin  (B).  The  points  are  the 
experimental data. The solid curve was calculated from Equation (4) (see Experimental 
Section). 
 
A  typical  feature of the aggregation curves  is  the  appearance of a lag period. To estimate the 
duration of the lag period, the initial  parts of the dependences  of  I on time were  analyzed using 
Equation (1) (see Experimental Section) containing parameters t2 (the duration of lag period; in other 
words, the point in time at which the light scattering intensity begins to increase) and parameter Kagg Int. J. Mol. Sci. 2010, 11                       
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characterizing the initial rate of aggregation. As an example, Figure 2 shows the fitting of the initial 
parts  of  the  dependences  of  I  on  time  obtained  at  concentrations  of  insulin  of  0.20,  0.28  and  
0.40 mg/mL. 
Figure 2. Analysis of the initial parts of the dependences of the light scattering intensity (I) 
on time for DTT-induced aggregation of insulin. The concentrations of insulin were as 
follows: 0.20 (1), 0.28 (2) and 0.40 (3) mg/mL. The final concentration of DTT is 20 mM. 
Points are the experimental data. Solid curves were calculated from Equation (1). 
 
The values of parameters t2 and Kagg calculated at various concentrations of insulin are given in 
Table  1.  The  duration  of  lag  period  decreases  from  18.4  0.5  to  15.6  0.2  min,  when  the 
concentration of insulin increases in the interval from 0.2 to 0.4 mg/mL. More significant changes are 
observed in the Kagg value. Parameter Kagg, which is a measure of the aggregation rate, increases by a 
factor of 200 at twofold increase in the concentration of insulin (from 0.2 to 0.4 mg/mL). Figure 1B 
shows the dependence of parameter Kagg on the concentration of insulin. The dependence follows the 
power law in accordance with Equation (4). Parameter n was found to be 6.3  0.2. 
Table 1. Parameters of DTT-induced aggregation of insulin at 25 C in 50 mM sodium 
phosphate buffer, pH 7.0, containing 0.15 M NaCl.  
[Insulin]  
(mg/mL) 
t1 (min)  t2 (min) 
Kagg, 
(counts/s min
−2) 
Rh,0 (nm)  t3 (min)  K1 (nm/min)  t* (min)  df
 
0.20  18.5  18.4  0.5   8.4  0.6  84  3  31.3  0.4  11.9  0.5  47  1.80  0.01 
0.24  18.3  18.3  0.5  25  2  81  2  29.0  0.3  13.6  0.6  42  1.80  0.01 
0.28  17.7  17.5  0.2  144  3  101  3  26.2  0.3  20.3  0.6  38  1.80  0.01 
0.32  17.2  16.7  0.2  460  10  100  2  19.3  0.2  26.6  0.9  28  1.80  0.01 
0.36  16.8  16.2  0.2  1270  20  100  2  18.1  0.1  31.0  0.8  24  1.79  0.01 
0.40  16.2  15.6  0.2  1690  30    99  3  17.7  0.2  60  2  22  1.79  0.01 
t1  is  the  time  of  appearance  of  the  start  aggregates;  t2  (the  duration  of  the  lag  period  of  the 
dependences of the light scattering intensity on time) and Kagg (parameter characterizing the initial 
rate  of  aggregation)  were  calculated  from  Equation  (1)  (see  Experimental  Section);  Rh,0  is  the 
average value of the hydrodynamic radius of the start aggregates; t3 is the point in time, at which 
the hydrodynamic radius of the start aggregates begins to increase; K1 is a constant calculated from 
Equation (2); t* is the point in time above which the dependence of Rh on time follows the power 
law represented by Equation (3); df is the fractal dimension of the aggregates. Int. J. Mol. Sci. 2010, 11                       
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Consider the time-course of the appearance of the protein aggregates in the solution of insulin after 
the addition of DTT. Figure 3 shows the insulin distribution of the particles by size (0.32 mg/mL) 
incubated at 25 C in the presence of 20 mM DTT. The particle size distributions were recorded at 
15 second intervals. Over the first 17 minutes, the single peak with Rh = 1.3  0.1 nm is registered in 
the system (Figure 3A; t = 1 min). It is evident that this peak corresponds to the non-aggregated form 
of insulin. At t = 17.2 min the start aggregates, with Rh value higher than 90 nm, appear, and two peaks 
are registered on the distribution of the particles by size (Figure 3B). The point in time at which the 
start aggregates appear, was designated as t1. It should be noted that intermediates between the peaks 
corresponding  to  the  non-aggregated  form  of  insulin  and  start  aggregates  are  lacking.  Thus,  the 
formation of the start aggregates proceeds on an all-or-none principle. 
Figure  3.  The  distribution  of  the  particles  by  size  for  insulin.  Insulin  (0.32  mg/mL)  was 
incubated at 25 C in the presence of 20 mM DTT for 1 (A), 17.2 (B), 19.3 (C) and 50 (D) min.  
 Int. J. Mol. Sci. 2010, 11                       
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In the interval from 17.2 to 19.3 min, the position of the peak corresponding to the start aggregates 
remains  unchanged  (see,  for  example,  Figure  3C).  Since  the  moment  in  time  at  which  the  start 
aggregates appear (t = 17.2 min), is very close to the precise moment at which the light scattering 
intensity begins to increase (t2 = 16.7 min), one can conclude that the increase in the light scattering 
intensity in the interval from 16.7 to 19.3 min is due to accumulation of the start aggregates in the 
system; the size of the start aggregates remaining unchanged. At t > 19.3 min the size of the start 
aggregates  begins  to  increase.  Figure  3D  shows  the  particle  size  distribution  at  t  =  50  min.  The 
hydrodynamic radius of the protein aggregates reaches a value of about 800 nm. 
The analogous character of the changes in the particle size distribution in the solution of insulin 
after the addition of DTT was observed for other insulin concentrations (0.20, 0.24, 0.28, 0.36 and 
0.40 mg/mL). The values of parameters t1 and t2 determined at various insulin concentrations are given 
in Table 1. 
The  time-course  of  the  positions  of  the  peaks  on  the  distribution  of  the  particles  by  size  for 
DTT-induced aggregation of insulin at various concentrations of the protein substrate (in the interval 
from 0.20 to 0.40 mg/mL) is demonstrated in Figure 4. The solid and open circles correspond to the 
non-aggregated and aggregated forms of insulin, respectively. The insets show the dependences of Rh 
on time with the expanded ordinate axis. 
A distinctive feature of the dependences of the hydrodynamic radius of the protein aggregates on 
time is the constancy of the Rh values over the definite time interval. This region of the Rh values 
corresponds to the start aggregates. The hydrodynamic radius of the start aggregates (Rh,0) remains 
practically unchanged at variation of the protein concentration (Table 1). The average value of Rh,0 was 
found to be 94  7 nm.  
As can be seen in Figure 4, at a definite moment in time the hydrodynamic radius of the start 
aggregates begins to increase. This moment in time was designated as  t3. The reason for such an 
increase in the Rh value is the sticking of the start aggregates provoked by their accumulation. The 
initial increase in the Rh value in time is linear. This allows the value of t3 to be determined more 
precisely using Equation (2). The values of parameter t3 are given in Table 1. The analysis of the 
values of t2 and t3 shows that the time interval (t3 − t2), over which the accumulation of the start 
aggregates occurs without sticking, is shortened by increasing the protein concentration.  
Apart from parameter t3, Equation (2) gives parameter K1, which characterizes the increase in the Rh 
value  in  time  (K1  =  dRh/dt).  The  values  of  parameter  K1  are given  in  Table  1.  When  the  insulin 
concentration increases from 0.2 to 0.4 mg/mL, a fivefold increase in the K1 value is observed. The 
data presented in Figure 3 show that above a definite point in time (t  t*), the dependence of Rh on 
time follows the power law  (see Equation  (3). The values of  t* and the fractal dimension of the 
aggregates (df) are given in Table 1. The fact that the values of df are close to 1.8 is indicative of the 
fulfillment of the regime of the diffusion-limited cluster-cluster aggregation.  Int. J. Mol. Sci. 2010, 11                       
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Figure 4. Analysis of the size of the particles in the solution of insulin after the addition of 
DTT. The dependences of the hydrodynamic radius (Rh) of the non-aggregated form of 
insulin (solid circles) and protein aggregates (open circles) on time. The concentrations of 
insulin were as follows: 0.20 (A), 0.28 (B), 0.32 (C) and 0.40 (D) mg/mL. The solid curves 
were calculated from Equation (3). Insets show the dependences of Rh on time with the 
expanded ordinate axis. The horizontal dotted lines correspond to the hydrodynamic radius 
of start aggregates (Rh,0). The solid lines are calculated from Equation (2). 
 Int. J. Mol. Sci. 2010, 11                       
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2.2. The Effect of -Crystallin on the Kinetics of Dithiothreitol-Induced Aggregation of Insulin 
To characterize the effect of -crystallin on the kinetics of DTT-induced aggregation of insulin, we 
analyzed the time-course of the light scattering intensity (I) and the hydrodynamic radius values of the 
particles formed in the solution of insulin (0.32 and 0.4 mg/mL), after the addition of DTT in the 
presence of various concentrations of -crystallin, in the interval from 0.08 to 1.2 mg/mL. Figure 5 
shows the kinetic curves of aggregation in the coordinates {I; time}. When the concentration of insulin 
was  0.4  mg/mL,  the  effect  of  -crystallin  is  clearly  visible.  The  relatively  low  concentrations  of 
-crystallin  (0.08,  0.32  and  0.64  mg/mL;  curves  2,  3  and  4  in  Figure  5B,  respectively)  induce 
acceleration  of  insulin  aggregation.  At  higher  concentrations  of  -crystallin  (0.8  and  1.2  mg/mL; 
curves 5 and 6, respectively) the suppression of insulin aggregation is observed.  
Figure 5. The effect of -crystallin on the kinetics of DTT-induced aggregation of insulin 
at the concentrations of 0.32 (A) or 0.4 (B) mg/mL. The final concentration of DTT was 
20 mM.  The  dependences  of  the  light  scattering  intensity  (I)  on  time  at  the  following 
concentrations  of  -crystallin:  0  (1),  0.08  (2),  0.32  (3),  0.64  (4),  0.8  (5)  and 
1.20 (6) mg/mL. 
 
 
At the insulin concentration of 0.4 mg/mL, the decrease in the rate of aggregation with increasing 
-crystallin concentration is accompanied by the gradual increase in the duration of lag period. When 
the insulin concentration was 0.32 mg/mL, the accelerating effect of low concentrations of -crystallin 
(0.08,  0.32  and  0.64  mg/mL;  curves  2,  3  and  4,  respectively)  and  inhibiting  action  of  high 
concentrations  of  -crystallin  (1.2  mg/mL;  curve  6  in  Figure  5A),  are  also  markedly  expressed. 
However, in general, the character of the effect of -crystallin on the insulin aggregation is more 
complicated because the decrease in the aggregation rate with increasing -crystallin concentration is 
not accompanied by such a pronounced increase in the duration of lag period as in the case of insulin 
concentration of 0.4 mg/mL. Int. J. Mol. Sci. 2010, 11                       
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It is evident that to characterize the effects caused by different concentrations of -crystallin, we 
should understand how -crystallin influences the duration of lag period, and also understand the 
initial  rate  of  aggregation.  Figure  6  shows  that  the  initial  parts  of  the  dependences  of  the  light 
scattering intensity on time may be satisfactorily described by Equation (1). Thus, the use of this 
equation enables estimating parameters t2 (the duration of lag period) and Kagg (the measure of the 
initial rate of aggregation). The values of parameters t2 and Kagg calculated at the insulin concentrations 
of 0.32 and 0.4 mg/mL and various concentrations of -crystallin are given in Table 2. As for the 
duration of lag period, parameter t2 becomes lower than the corresponding values measured in the 
absence of -crystallin (t2 = 16.7 or 15.6 min at the insulin concentration of 0.32 or 0.4 mg/mL, 
respectively). However, at relatively high concentrations of -crystallin, the values of t2 exceed the 
control values. At the molar stoichiometric ratio (insulin:-crystallin) less than 1:0.5, a pronounced 
accelerating effect of -crystallin was observed, whereas at the ratio exceeding the value of 1:0.6  
-crystallin  caused  suppression  of  insulin  aggregation.  These  effects  could  be  observed  at  the 
concentrations of -crystallin exceeding 0.64 and 0.8 mg/mL in the experiments with insulin at the 
concentration of 0.32 and 0.4 mg/mL, respectively (Table 2).  
Table  2. Parameters of DTT-induced aggregation of insulin in the presence of various 
concentrations of -crystallin. 
[-Crystallin] 
(mg/mL) 
t2 (min)  Kagg (counts/s min
−2) 
Rh,complex 
(nm) 
t3 (min)  K1 (nm/min) 
Concentration of insulin 0.32 mg/mL 
0.00  16.7  0.1  460  10       
0.08  6.4  0.1  3460  50  24.6  1.2  6.5  0.2  76.0  5.0 
0.16  8.6  0.1  2130  50  24.6  1.1  9.1  0.3  56.0  4.0 
0.32  9.3  0.1  1620  50  20.6  0.8  10.0  0.1  35.0  2.0 
0.48  9.8  0.2  600  20  22.3  1.2  10.4  0.1  23.5  1.9 
0.64  10.4  0.1  300  6  21.0  0.8  11.1  0.1  18.4  0.8 
0.80  11.4  0.1  132  3  18.4  0.8  11.8  0.2  13.0  0.5 
1.00  17.2  0.3  119  4  19.5  0.8  17.7  1.1  9.0  0.5 
1.20  18.9  0.5  28  3  18.9  0.5  19.4  1.4  5.6  0.5 
Concentration of insulin 0.4 mg/mL 
0.00  15.6  0.1  1690  30       
0.08  4.5  0.1  17600  350  22.6  1.2  5.4  0.1  82  6 
0.32  8.5  0.1  5100  100  21.8  0.8  9.1  0.2  71  5 
0.64  13.2  0.1  2500  100  23.1  1.1  13.8  0.5  63  2 
0.80  17.2  0.1  840  10  21.6  0.8  17.9  1.1  48.4  1.8 
1.00  21.9  0.1  540  10  21.2  1.0  22.3  1.2  23.0  1.0 
1.20  27.6  0.1  321  8  21.4  0.9  27.9  1.1  11.0  0.8 
t2 (the duration of the lag period of the dependences of the light scattering intensity on time) and 
Kagg (parameter characterizing the initial rate of aggregation) were calculated from Equation (1); 
Rh,complex is the hydrodynamic radius of the complex of -crystallin with the insulin B chain; t3 is the 
point in time at which the Rh value begins to increase; K1 is a constant calculated from Equation (2). Int. J. Mol. Sci. 2010, 11                       
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Figure  6.  The  analysis  of  the  initial  parts  of  the  dependences  of  the  light  scattering 
intensity  (I)  on  time  for  DTT-induced  aggregation  of  insulin  (0.32  mg/mL).  The  final 
concentration  of  DTT  was  20  mM.  The  concentrations  of  -crystallin  were  as  follows:  
0.08  (1),  0.16  (2),  0.64  (3)  and  0.80  (4)  mg/mL.  The  solid  curves  are  calculated  from 
Equation (1). 
 
 
Figure 7 shows the dependences of the hydrodynamic radius of the protein aggregates formed in the 
solution of insulin (0.32 mg/mL) on time after the addition of DTT in the presence of -crystallin at 
concentrations of 0.08, 0.32, 0.64 and 0.8 mg/mL (curves 1, 2, 3 and 4, respectively). As can be seen 
from Figure 7, the higher the concentration of -crystallin, the lower the size of the aggregates. 
Figure 7. The dependences of the hydrodynamic radius (Rh) of the particles formed upon 
addition  of  DTT  to  the  solution  of  insulin  (0.32  mg/mL)  on  time  in  the  presence  of 
-crystallin. The concentrations of -crystallin were as follows: 0.08 (1), 0.32 (2), 0.64 (3), 
and 0.80 (4) mg/mL. 
 
The shape of the initial parts of the dependences of Rh on time is of special interest. As an example, 
Figure 8 shows the initial parts of such dependences in the presence of -crystallin at the concentration 
of 0.08 mg/mL (Figure 8A) and 0.8 mg/mL (Figure 8B).  Int. J. Mol. Sci. 2010, 11                       
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Figure  8.  The  analysis  of  the  initial  parts  of  the  dependences  of  the  hydrodynamic 
radius (Rh) on time for aggregation of insulin (0.32 mg/mL) in the presence of -crystallin. 
The concentrations of -crystallin were 0.08 (A) and 0.80 (B) mg/mL. Solid lines were 
calculated from Equation (2). 
 
 
Immediately after the addition of DTT, the particles with Rh = 24.6  1.2 nm (Figure 8A) and 
18.4  0.8 nm (Figure 8B) are registered in the system. The value of Rh remains constant over 6.5 and 
11.8 min, respectively. When interpreting these results, we take into account that judging from the 
DLS measurements, the hydrodynamic radius of the -crystallin preparation used in the present work 
was 13.2  0.1 nm. One can assume that the particles with Rh = 24.6 and 18.4 nm are the complexes of 
-crystallin with the insulin B chain. Let us designate the hydrodynamic radius of these complexes as 
Rh,complex.  At  a  definite  point  in  time,  the  hydrodynamic  radius  of  the  primary  particles  begins  to 
increase. The linear parts of the increase in the Rh value in time were treated using an Equation (5). 
Parameters K1 and t3 are given in Table 2. The comparison of the values of t2 and t3 shows that the 
moment in time at which the light scattering intensity begins to increase (t2), coincides with the time at 
which the size of the -crystallin–insulin B chain complexes begins to increase (t3). The rate of the 
increase in the Rh value in time (parameter K1) gradually decreases on increasing the  -crystallin 
concentration.  
Figure  9A  and  B  demonstrates  the  dual  effect  of  -crystallin  on  the  initial  rate  of  insulin 
aggregation. The horizontal dotted lines in this figure correspond to the Kagg value measured in the 
absence of -crystallin (
control
agg K ). If the values of Kagg are located above the control level, acceleration 
of insulin  aggregation takes  place, whereas  the  Kagg  values below the  control  level  correspond to 
suppression  of  aggregation.  To  determine  -crystallin  concentration,  at  which  the  initial  rate  of Int. J. Mol. Sci. 2010, 11                       
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aggregation coincides with the value of Kagg measured in the absence of -crystallin, we used the 
Equation (6).  
It should be noted that Kagg,0 is the expected value of Kagg, if the mechanism of insulin aggregation 
realized in the presence of -crystallin remains intact at C  0. Since the mechanisms of insulin 
aggregation which are operative in the presence or in the absence of -crystallin are different, the 
Kagg,0 value is not identical to 
control
agg K . The following values of parameters Kagg,0, C0.5 and h were found 
using  this  equation:  Kagg,0  =  2180    40  (counts/s)· min
−2,  C0.5  =  0.40    0.01  mg/mL  and  
h = 4.3  0.2 at the insulin concentration of 0.32 mg/mL, and Kagg,0 = 5310  160 (counts/s)· min
−2, 
C0.5 = 0.62  0.02 mg/mL and h = 5.4  0.5 at the insulin concentration of 0.4 mg/mL. 
Figure 9. Analysis of parameters Kagg and t2 used for description of the dependences of the 
light scattering intensity on time for DTT-induced aggregation of insulin in the presence of 
various  concentrations  of  -crystallin.  The  dependences  of  parameter  Kagg  on  the 
concentration  of  -crystallin  at  the  concentrations  of  insulin  of:  0.32  (A)  and 
0.4 (B) mg/mL.  The  horizontal  dotted  lines  correspond  to  the  Kagg  values  obtained  for 
insulin aggregation in the absence of -crystallin (
control
agg K ). The solid curves were drawn 
from  Equation  (5).  The  relationships  between  Log  Kagg  and  parameter  t2  at  the 
concentrations of insulin of: 0.32 (C) and 0.4 (D) mg/mL. Crosses correspond to insulin 
aggregation in the absence of -crystallin. 
 
With the knowledge of these parameters, we calculated the concentration of -crystallin (С*), at 
which the Kagg value is numerically equal to 
control
agg K : 
control 1/
0.5 agg,0 agg * ( / 1)
h C C K K  . The values of 
control
agg K  are equal to 460 and 1690 (counts/s)· min
−2 at the insulin concentration of 0.32 and 0.4 mg/mL, 
respectively. The corresponding values of C* were found to be 0.55 and 0.71 mg/mL, respectively. 
Insets in Figure 9C and D show the relationships between the parameters Kagg and t2 in the coordinates 
{logKagg;  t2}.  When  the  concentration  of  insulin  was  0.4  mg/mL,  the  point  with  coordinates Int. J. Mol. Sci. 2010, 11                       
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corresponding  to  the  values  of  Kagg  and  t2,  measured  in  the  absence  of  -crystallin  (this  point  is 
designated by a cross), fall on the curve connecting the points corresponding to Kagg and t2 values 
measured  in  the  presence  of  -crystallin.  This  explains  the  fact  that  the  effect  of  -crystallin  on 
aggregation  of  insulin  is  clearly  visible  when  the  concentration  of  -crystallin  was  0.4  mg/mL 
(Figure 5B). As for the dependence of log Kagg on t2 at the insulin concentration of 0.32 mg/mL, the 
point corresponding to the control values of Kagg and t2 lies outside the curve connecting the points 
corresponding to the Kagg and t2 values measured in the presence of -crystallin. This results in the 
complicated influence of -crystallin on insulin aggregation (Figure 5A).  
It was of interest to study the effect of -crystallin on the shape of the dependences of the initial 
rate of aggregation characterized by parameter Kagg on the insulin concentration. Figure 10 shows these 
dependences obtained in the absence (curve 1) and in the presence of -crystallin at the concentrations 
of 0.08 and 1.2 mg/mL (curves 2 and 3, respectively). First of all, the dependences of parameter Kagg 
on  the  insulin  concentration  presented  in  this  figure  demonstrate  the  accelerating  effect  of  the 
relatively  low  concentrations  of  -crystallin  (curve  2)  and  the  inhibiting  action  of  rather  high 
concentrations of -crystallin (curve 3). Furthermore, the dependences under discussion obtained in 
the  presence  of  -crystallin,  similar  to  the  corresponding  dependence  obtained  in  the  absence  of 
-crystallin,  follow  the  power  law  presented  by  Equation  (4).  The  value  of  parameter  n  at  the 
-crystallin concentration of 0.08 mg/mL (n = 7.8  0.2) exceeds the corresponding value obtained in 
the absence of -crystallin (n = 6.3  0.2). When the concentration of -crystallin was 1.2 mg/mL, the 
value of this parameter (n = 5.9  0.2) was close to that for the dependence of parameter Kagg on the 
insulin concentration obtained in the absence of -crystallin. 
Figure  10.  The  effect  of  -crystallin  on  the  dependence  of  parameter  Kagg  on  the 
concentration  of  insulin.  The  concentrations  of  -crystallin  were  as  following:  0  (1),  
0.08 (2) and 1.20 (3) mg/mL. The points are the experimental data; the solid curves were 
calculated from Equation (4). 
 
2.3. Fluorescence Studies of -Crystallin Interaction with Insulin 
The  formation  of  the  complex  between  two  proteins  was  also  confirmed  by  the  tryptophan 
fluorescence measurements. Since -crystallin, but not insulin, contains tryptophan residues, we used 
fluorescence spectroscopy to examine the tryptophan emission spectra of the individual -crystallin 
and the chaperone within the complex -crystallin–insulin. -crystallin taken alone gives fluorescence Int. J. Mol. Sci. 2010, 11                       
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spectra with emission maximum at 335 nm (data not shown). The results of the experiments show that 
insulin, in its original form, does not bind to -crystallin. In the absence of DTT, the fluorescence 
intensity values are almost equal to those of the sum of the individual fluorescence emission spectra of 
insulin and -crystallin (data not shown), implying that there was little, if any, interaction between the 
two proteins. Only the aggregation-prone reduced insulin was found to interact with -crystallin. On 
reduction of disulfide bonds of insulin by DTT, an almost immediate increment on the dependences of 
the relative fluorescence intensity on time registered at 335 nm was observed. However, no shift in the 
emission maximum of intrinsic fluorescence was detected. 
At  the  -crystallin  concentration  of  0.3  mg/mL,  the  increment  was  shown  to  increase  in  a 
concentration-dependent manner in the presence of insulin at concentrations from 0.2 to 0.6 mg/mL 
(Figure  11A,  curves  5–8,  respectively)  corresponding  to  the  molar  stoichiometric  ratio  
(insulin:-crystallin)  less  than  1:0.5.  The  increase  in  the  intensity  of  tryptophan  fluorescence  of  
-crystallin, under the conditions of the appearance of aggregation-prone reduced insulin, suggests that 
the  -crystallin–insulin  complex  is  formed  and  that  the  tertiary  structure  of  the  complex  is  more 
compact than that of the individual chaperone [22].  
At  molar  stoichiometric  ratio  (insulin:-crystallin)  exceeding  the  value  of  1:0.6,  at  which 
-crystallin caused suppression of insulin aggregation, almost no increment on the dependences of the 
relative fluorescence intensity on time was shown (Figure 11A, curves 2 and 3). Bovine -crystallin 
possesses no disulphide bonds and therefore no change in its tryptophan emission spectrum could be 
observed upon addition of DTT; however, a quenching of tryptophan emission intensity by DTT was 
detected, the most pronounced effect being revealed in the absence of insulin (Figure 11A, curve 1). 
The  dependence  of  the  relative  increment  of  the  fluorescence  intensity  (Fmax/F0)  on  the 
concentration  of  insulin  is  also  shown  (Figure  11B),  where  F0  is  the  minimum  value  of  the 
fluorescence intensity reached immediately after the addition of insulin, and Fmax is the maximum 
value  of  the  fluorescence  intensity.  At  the  fixed  concentration  of  -crystallin  (0.3  mg/mL),  the 
increment  amplitude  gradually  increased  at  a  concentration  of  insulin  in  the  range  from  0.05  to 
0.4 mg/mL; whereas at higher insulin concentrations, no further increase of the relative fluorescence 
intensity (Fmax/F0) was observed. 
In our experiments, an increase in tryptophan fluorescence of -crystallin in the presence of insulin 
after the addition of DTT is followed by a gradual decrease in the fluorescence intensity at further 
incubation (Figure 11A, curves 4–8). The moment in time at which the fluorescence intensity begins to 
decrease, correlates well with the kinetics of DTT-induced aggregation of insulin (data not shown). 
Thus, the diminishing of the fluorescence intensity at rather high values of time is due to the increase 
in turbidity of the solution. Int. J. Mol. Sci. 2010, 11                       
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Figure  11.  The  interaction  between  insulin  and  -crystallin  monitored  by  tryptophan 
fluorescence. (A) The dependences of the relative fluorescence intensity on time of the 
solution containing -crystallin at the concentration of 0.3 mg/mL (1) or the mixtures of 
-crystallin (0.3 mg/mL) and insulin at the concentrations of 0.1 (2), 0.12 (3), 0.16 (4), 
0.2 (5), 0.3 (6), 0.4 (7) and 0.6 (8) mg/mL. The arrow shows the moment of addition of 
DTT. The final concentration of DTT was 20 mM. The fluorescence was recorded at 25 C 
in 50 mM sodium phosphate buffer, pH 7.0, containing 0.15 M NaCl upon excitation and 
emission  at  297  and  335  nm,  respectively;  (B)  Dependence  of  the  increment  of  the 
fluorescence intensity (Fmax/F0) on the concentration of insulin. F0 is the minimum value of 
the fluorescence intensity reached immediately after the addition of insulin and Fmax is the 
maximum value of the fluorescence intensity. 
 
3. Discussion 
First of all, consider what information may be obtained from analysis of the dependences of the 
initial aggregation rate characterized by parameter Kagg, which is calculated from the light scattering 
intensity versus time plots, on the concentration of the protein substrate. In [23], where the quadratic 
equation was proposed for the description of the dependence of the light scattering intensity on time, 
the dependence of parameter Kagg on the concentration of the protein substrate was analyzed for heat 
aggregation of glycogen phosphorylase b from rabbit skeletal muscle. The experimental data obtained 
by  Kornilaev  et  al.  [24]  were  used  for  the  construction  of  the  parameter  Kagg  versus  glycogen 
phosphorylase b concentration plot. It was found that parameter Kagg was a linear function of the 
glycogen phosphorylase b concentration. This means that parameter n in Equation (4) is equal to unity 
and, consequently, the rate-limiting stage of the overall process of aggregation is the monomolecular Int. J. Mol. Sci. 2010, 11                       
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stage of unfolding of the protein molecule. This conclusion agrees with the mechanism of thermal 
denaturation of glycogen phosphorylase b, established by Kurganov et al. [25]. The kinetic scheme of 
thermal denaturation of glycogen phosphorylase b, involves the stage of the conformational change of 
the  dimeric  molecule  of  the  enzyme,  followed  by  dissociation  of  dimer  into  monomers,  and 
denaturation of labile monomeric forms. 
When studying DTT-induced aggregation of -lactalbumin [3], we showed that unfolding of the 
-lactalbumin molecule proceeded immediately after the addition of DTT. Thus, the rate-limiting stage 
of the process of -lactalbumin aggregation corresponds to the stage of the interaction of the unfolded 
protein molecules, namely the nucleation stage. The analysis of the dependence of parameter Kagg on 
the concentration of -lactalbumin presented in the work [3] shows that parameter n calculated from 
Equation (4) is equal to 3.5  0.2. The fact that the value of parameter n exceeds unity, is indicative of 
the involvement of several molecules of unfolded -lactalbumin in the nucleation process. The results 
of  the  study  of  DTT-induced  aggregation  of  insulin  carried  out  in  the  present  work,  show  that 
parameter n essentially exceeds unity (n  6). By this is meant that the rate-limiting stage of the 
process  of  DTT-induced  aggregation  of  insulin,  as  in  the  case  of  DTT-induced  aggregation  of  
-lactalbumin, is the stage of nucleation. 
It  is  generally  accepted  that  the  appearance  of  lag  phase  on  the  kinetic  curves  of  aggregation 
indicates that the initial stage of aggregation is the stage of nucleation [23,26–33]. The formation of a 
nucleus proceeds as a result of cooperative association of several molecules of the unfolded protein 
substrate. The study of the kinetics of protein aggregation using DLS showed that the nuclei could not 
be detected because of their rapid sticking to form large-sized assemblies. It has beenthese large-sized 
assemblies that are registered as start aggregates by DLS [3,34]. 
The  estimation  of  the  size  of  the  protein  aggregates  formed  in  the  course  of  DTT-induced 
aggregation of insulin, showed that the initially registered aggregates are the start aggregates with a 
hydrodynamic  radius  of  94  7  nm.  It  is  of  interest  that  the  size  of  the  start  aggregates  remains 
unchangeable on variation of the insulin concentration. This fact allows us to draw an analogy between 
the formation of the start aggregates and micelle formation. In the latter case, the micelles of a definite 
size  are  formed  when  the  critical  micelle  concentration  is  achieved.  Such  an  analogy  offers  
an  explanation  for  the  fact  that  the  formation  of  start  aggregates  proceeds  according  to  the  
all-or-none principle. 
The analyses of the dependences of the hydrodynamic radius of the protein aggregates on time for 
DTT-induced aggregation of insulin showed that the Rh value did not approach the limiting value even 
after  prolonged  incubation.  The  increase  in  the  Rh  value  over  time  follows  the  power  law 
(Rh  t
1/1.8 = t
0.56). The df value calculated from Equation (3) was found to be close to 1.8. This fact 
suggests that the growth of the start aggregate proceeds as a result of sticking of the start aggregates, 
rather than due to the attachment of the unfolded insulin molecule to a nucleus, as is postulated in the 
nucleation-dependent models of aggregation. 
When studying the effect of -crystallin on the kinetics of DTT-induced aggregation of insulin, we 
demonstrated that relatively high concentrations of -crystallin suppressed insulin aggregation. This 
result  agrees  with  the  traditional  point  of  view  that  the  main  function  of  -crystallin,  as  a 
representative  of  the  family  of  small  heat  shock  proteins,  is  a  suppression  of  aggregation  of  the 
unfolded  protein  molecules  while  maintaining  non-native  proteins  in  a  refolding  competent Int. J. Mol. Sci. 2010, 11                       
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conformation [1]. However, detailed studies of the effect of low concentrations of -crystallin on the 
kinetics of DTT-induced aggregation of protein substrates have not yet been conducted. 
The results obtained in the present work clearly demonstrate that relatively low concentrations of 
-crystallin accelerate DTT-induced aggregation of insulin. Such an effect of  -crystallin may be 
provoked by the stimulation of the nucleation stage as a result of binding of the unfolded insulin B 
chain to the surface of the -crystallin particle. To clarify this idea, Scheme 1 illustrates DTT-induced 
aggregation of insulin in the presence of low concentrations of -crystallin. State I in this scheme is a 
demonstration of the components initially present in the system, namely -crystallin particles (1) and 
unfolded B chain of insulin [2]. The high values of (unfolded B chain of insulin):(-crystallin) ratio 
favor filling of the surface of the -crystallin particle by adsorbed B chain of insulin (state II). The 
high local concentrations of unfolded protein molecules on the surface of the  -crystallin particle 
facilitates the stage of nucleation, which should be called the heterogeneous nucleation because it 
proceeds on the surface of the rather large particle [35] (state III). In the scheme, nuclei are depicted as 
“nodules” on the surface of the -crystallin particle. The formed nuclei serve as the points of growth of 
the  aggregates  including  the  unfolded  B  chains  of  insulin  (state IV).  Owing  to  concentrating  the 
unfolded protein molecules on the surface of the -crystallin particle, the heterogeneous nucleation in 
the presence of -crystallin proceeds more effectively than the homogenous nucleation of the unfolded 
protein in the absence of -crystallin. This explains the acceleration of DTT-induced aggregation of 
insulin in the presence of relatively low concentrations of -crystallin. 
Scheme 1. Schematic representation of DTT-induced aggregation of insulin in the presence 
of relatively  low  concentrations  of  -crystallin causing  acceleration of the aggregation 
process (1 is the -crystallin particle and 2 is the unfolded B chain of insulin).  
 
Consider the region of the -crystallin concentrations where the chaperone acts as a suppressor of 
insulin aggregation (Scheme 2). At rather low values of (unfolded B chain of insulin):(-crystallin) 
ratio interaction of chaperone and the protein substrate results in the formation of the complexes which 
are not prone to aggregation (state II in Scheme 2). However, after a certain period of time aggregation 
of  these  complexes  occurs  (see,  for  example,  Figure  8).  The  initial  stage  of  aggregation  is  the 
formation of nuclei on the surface of the -crystallin particle (state III in Scheme 2). At -crystallin 
concentrations under discussion, a relatively low density of adsorbed insulin B chains on the surface of 
the -crystallin particle hampers the formation of nuclei. The higher the -crystallin concentration, the 
higher the duration of the lag period (i.e., the higher the t3 value; see Table 2). The nuclei formed on 
the surface of the -crystallin particle, serve as the sticky sites providing aggregation of the unfolded 
protein–-crystallin complexes (state IV in Scheme 2).  Int. J. Mol. Sci. 2010, 11                       
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Scheme 2. Schematic representation of DTT-induced aggregation of insulin in the presence 
of relatively high concentrations of -crystallin, causing suppression of the aggregation 
process (1 is the -crystallin particle and 2 is the unfolded B chain of insulin). 
 
 
One can assume that in the region of -crystallin concentrations where the rates of aggregation 
measured  in  the  absence  or  in  the  presence  of  -crystallin  are  comparable,  both  mechanisms  of 
aggregation presented in Schemes 1 and 2 are realized. 
Thus, the results of the present work suggest that heterogeneous nucleation plays the key role in the 
realization of the mechanisms of DTT-induced aggregation of insulin proceeding in the presence of a 
molecular chaperone, -crystallin. At rather high concentrations of  -crystallin, it has been solely 
heterogeneous  nucleation  with  the  participation  of  unfolded  protein  molecules  rather  sparsely 
distributed on the surface of the -crystallin particle, which determines the delay in the aggregation 
process and relatively low rate of aggregation. At rather low concentrations of -crystallin, drawing 
together  of  the  unfolded  protein  molecules  on  the  surface  of  the  -crystallin  particle,  favors 
heterogeneous nucleation and provides the higher rate of aggregation. 
The latter case may have substantial biological relevance. In response to a cellular stress, which 
generates a large amount of misfolded or partially folded proteins (hyperthermia, overexpression of 
insoluble  or  mutant  proteins,  etc.),  cells  are  protected  from  accumulating  protein  aggregates  by 
mechanisms  involving  the  suppression  of  aggregate  formation  by  molecular  chaperones  and 
degradation of pathogenic proteins by the ubiquitin-proteasome pathway. At the initial stages of the 
protein aggregation processes induced by different kinds of stress, the level of Hsp concentrations in a 
cell  may  be  rather  low.  Acceleration  of  protein  aggregation  triggered  by  Hsps  resulting  in  the 
formation  of  large-sized  aggregates  may  have  positive  consequences.  We  suggest  that  rapidly 
generated  amorphous  protein  aggregates  on  the  surface  of  Hsp  particles,  can  act  as  a  means  to 
concentrate the unfolded protein molecules within the cytosol of a cell in a manner analogous to the 
role of aggresomes [36,37]. An aggresome is a proteinaceous inclusion body that forms in response to 
a stress, when cellular  chaperoning or  degradation  machinery  is  impaired, leading to  a protective 
biological  effect  as  a  result  of  accumulation  of  abnormal  or  damaged  proteins  within  the 
inclusion bodies.  
In the present work, an accelerated targeting of the stress-induced unfolded protein substrate to the 
-crystallin  particles  is  assumed  to  be  a  protective  response,  resembling  that  of  an  aggresome, 
sequestering wide distribution of potentially toxic aggregates.  Int. J. Mol. Sci. 2010, 11                       
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4. Experimental Section 
4.1. Materials 
Human recombinant insulin and DTT were purchased from Sigma. All other chemicals were of 
reagent grade. All solutions for the experiments were prepared using deionized water obtained with 
Easy-Pure II RF system (Barnstead, U.S.). 
4.2. Isolation and Purification of -Crystallin 
Purification  of  -crystallin  from  freshly  excised  lenses  of  two-year-old  steers  was  performed 
according to the procedure described earlier [38]. The -crystallin concentration was determined from 
the absorbance at 280 nm using the extinction coefficient 
1%
280 A  of 8.5 [39]. 
4.3. DTT-Induced Aggregation of Insulin 
The  kinetics  of  insulin  aggregation  was  registered  in  50  mM  Na-phosphate  buffer,  pH  7.0, 
containing 0.15 M NaCl. Insulin was dissolved in 20 mM NaOH and then in sodium phosphate buffer 
to  a  concentration  of  1  mg/mL.  An  aliquot  of  this  solution  was  added  to  the  buffer  in  the  cell. 
Reduction of insulin (0.2–0.4 mg/mL) was initiated by adding DTT to 0.5 mL of the sample to a final 
concentration  of  20  mM.  To  study  the  effect  of  -crystallin  on  insulin  aggregation,  aliquots  of 
-crystallin solutions were added into the cell simultaneously with insulin. The experiments were 
performed at room temperature (25 C). 
4.4. Dynamic Light Scattering Studies 
DLS  measurements  were  performed  by  a  commercial  instrument  Photocor  Complex  (Photocor 
Instruments Inc., U.S.; www.photocor.com) as described in our previous works where DLS was used 
for the study of the kinetics of thermal and DTT-induced aggregation of proteins [3,40]. A He-Ne laser 
(Coherent, U.S., Model 31-2082, 632.8 nm, 10 mW) was used as a light source. The temperature of 
sample  cell  was  controlled  by  the  proportional  integral  derivative  (PID)  temperature  controller  to 
within 0.1 C. The quasi-cross correlation photon counting system with two photomultiplier tubes 
was used to increase the accuracy of particle sizing in the range from 1.0 nm to 5.0 m. DLS data have 
been  accumulated  and  analyzed  with  multifunctional  real-time  correlator  Photocor-FC.  DynaLS 
software  (Alango,  Israel)  was  used  for  polydispersity  analysis  of  the  DLS  data.  The  diffusion 
coefficient D of the particles is directly related to the decay rate c of the time-dependent correlation 
function  for  the  light-scattering  intensity  fluctuations:  D  =  1/2ck
2.  In  this  equation,  k  is  the 
wavenumber of the scattered light, k = (4n/)sin(/2), where n is the refractive index of the solvent,  
  is  the  wavelength  of  the  incident  light  in  vacuum  and    is  the  scattering  angle.  The  mean 
hydrodynamic radius of the particles  (Rh) can then be calculated according to the Stokes-Einstein 
Equation: D = kBT/6Rh, where kB is Boltzmann’s constant, T is the absolute temperature and  is the 
shear viscosity of the solvent.  
To  analyze  the  time-course  of  the  increase  in  the  light  scattering  intensity  (I)  accompanying 
aggregation  of  insulin,  we  used  the  approaches  elaborated  by  us  previously  [23].  The  following Int. J. Mol. Sci. 2010, 11                       
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designations were used. The time of the appearance of the start aggregates was designated as t1, and 
the designation t2 was used for the duration of the lag period on the dependences of the light scattering 
intensity on time. To calculate parameter t2, in the present work we used the empiric equation: 
I = Kagg(t − t2)
2            (1) 
where Kagg is a constant with the dimension of (counts/s)min
−2. Parameter Kagg characterizes the initial 
rate of aggregation.  
It  should  be  noted  that  in  some  of  our  previous  works  (see,  for  example  [3,41,42])  we  used 
Equation  (2)  in  the  form:  I  =  KLS(t  −  t2)
2.  The  constant  KLS  in  this  equation  has  the  following 
dimension: (counts/s)
1/2min
−1. DLS allows monitoring the course of the protein aggregation by the 
increase in the hydrodynamic radius (Rh) of the growing particles. In this case, the rate of aggregation 
may be characterized by the value of 1/t2R, where t2R is the time interval, over which the Rh value is 
doubled. Since the dimension of the 1/t2R value is min min
−1, we can directly compare parameter KLS, 
which is calculated from the dependences of the light scattering intensity on time, with parameter 1/t2R, 
which is calculated from the dependences of Rh on time. It is evident that parameters Kagg and KLS are 
connected by the following relationship: Kagg = (KLS)
2. 
To analyze the dependences of the hydrodynamic radius (Rh) of the protein aggregates on time for 
DTT-induced  aggregation  of  insulin,  we  used  the  approaches  applied  in  the  cases  of  thermal 
aggregation of proteins [40,43]. The following equation may be used for the description of the initial 
linear parts of the dependences of Rh on time:  
Rh = Rh,0 + K1(t − t3)            (2) 
where Rh,0 is the hydrodynamic radius of the start aggregates, t3 is the point in time at which the 
hydrodynamic radius of the start aggregates begins to increase and K1 is a constant. 
When  studying  the  kinetics  of  thermal  aggregation  of  proteins,  we  observed  that  the  typical 
dependences of the hydrodynamic radius (Rh) of the protein aggregates on time were as follows. The 
initial parts of the dependences of Rh on time were linear. Above the definite point in time designated 
as t* the dependences of Rh on time followed the power law. The following equation may be used for 
the description of these parts of the dependences of Rh on time:  
f / 1
2
*
h h )] ( 1 [
d t* t K R R                (3) 
where 
*
h R  is the Rh value at t = t*, K2 is a constant and df is the fractal dimension of the aggregates. 
The df value was found to be close to 1.8. This value of df is typical of the regime of diffusion-limited 
cluster-cluster  aggregation,  wherein  each  collision  of  the  interacting  particles  results  in  their 
sticking [44–46]. 
To analyze the dependence of parameter Kagg on the concentration of insulin, we used the equation: 
agg 0 [P]
n KB              (4) 
where  0 ] P [  is the initial concentration of the protein, n is the order of aggregation with respect to 
protein and B is a constant.  
The linear parts of the increase in the Rh value of the complexes of -crystallin with the insulin B 
chain  (designated  as  Rh,complex)  in  time  (Figure  8)  were  treated  using  an  equivalent  equation  to  
Equation (2): Int. J. Mol. Sci. 2010, 11                       
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Rh = Rh,complex + K1(t − t3)            (5) 
Parameters K1 and t3 are given in Table 2. 
To determine -crystallin concentration, at which the initial rate of aggregation coincides with the 
value of Kagg measured in the absence of -crystallin, we used the following empiric equation:  
agg,0
agg
0.5 1 ( / )
h
K
K
CC


            (6) 
where C is the -crystallin concentration, Kagg,0 is the limiting value of the function Kagg(C) at C  0, 
C0.5  is  the  -crystallin  concentration,  at  which  Kagg/Kagg,0  =  0.5,  and  h  is  a  constant  (the  Hill 
coefficient). 
4.5. Fluorescence Spectroscopy 
The  tryptophan  fluorescence  measurements  were  performed  using  a  Cary  Eclipse  fluorescence 
spectrophotometer (Varian, Inc.) with a temperature-controlled cuvette holder. Samples were excited 
at 297 nm and fluorescence emission spectra were recorded from 300 to 400 nm. The excitation and 
emission slit widths were set at 2.5 nm. Before measurement, protein samples (-crystallin or insulin) 
were  preincubated  for  10  min  at  25  C  in  50  mM  sodium  phosphate  buffer,  рН  7.0,  containing 
0.15 M NaCl.  The  interaction  between  two  proteins  was  initiated  by  addition  of  DTT  to  a  final 
concentration  of  20 mM.  The  incubation  mixtures  were  then  subjected  to  the  fluorescence 
measurements in a quartz cuvette with a 1 cm path length. In these experiments the time of sample 
exposition to illumination was minimized in order to avoid the UV-induced spectral effects as a result 
of reduction of S–S bonds and subsequent structural rearrangements in the protein molecule.  
The  dependences  of  the  relative  fluorescence  intensity  on  time  of  the  solutions  containing 
-crystallin (0.3 mg/mL), in the absence or presence of various concentrations of insulin, in the range 
from  0.1  to  0.6  mg/mL,  were  recorded  immediately  after  addition  of  DTT,  upon  excitation  and 
emission at 297 and 335 nm, respectively. Each spectrum was the average of 5 scans. 
5. Conclusions  
In the present study, we demonstrate that low concentrations of -crystallin, a member of the small 
heat  shock  protein  (Hsp)  family,  dramatically  accelerate  the  dithiothreitol-induced  aggregation  of 
model  protein  substrate,  human  recombinant  insulin;  whereas  high  concentrations  of  -crystallin 
suppress insulin aggregation. The mechanisms underlying the dual effect of -crystallin have been 
proposed. It is assumed that heterogeneous nucleation occurring on the surface of the -crystallin 
particle plays the key role in the paradoxical acceleration of insulin aggregation by -crystallin that 
may provide an alternative biologically significant pathway of the aggregation process. We suggest 
that  rapidly  generated  amorphous  protein  aggregates  on  the  Hsp  particles,  can  act  as  a  means  to 
concentrate the unfolded protein molecules within the cytosol of a cell in a manner analogous to the 
role of aggresomes. An accelerated targeting of the stress-induced unfolded protein substrate to the 
Hsp particles is assumed to be a protective response, resembling that of an aggresome, sequestering 
wide distribution of potentially toxic aggregates.  Int. J. Mol. Sci. 2010, 11                       
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